• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Pfizer Ltd.
    17 Dec 2024
    Board Meeting
    4413.20
    -1.03%
    In relief for investors, Pfizer 2025 profit forecast in line with estimates
    Business Standard
    Shares of the drugmaker rose nearly 3 per cent to $25.98 in premarket trading after the company also said it was expecting 2025 sales of its Covid-19 vaccine and drug to be consistent
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 151 to 129 in Mar 2025 qtr
    logo
    Aurobindo Pharma Ltd.
    17 Dec 2024
    1201.20
    -1.29%
    Aurobindo Pharma's Telangana API Facility Gets Two Observations From FDA
    Aurobindo Pharma's Telangana API Facility Gets Two Observations From FDA
    NDTV Profit
    The observations are of procedural in nature and will be responded to within the stipulated time, says Aurobindo Pharma.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. is trading above its 100 day SMA of 1179.1
    logo
    Granules India Ltd.
    17 Dec 2024
    505.60
    0.63%
    Granules India's Generic ADHD Drug Gets FDA Nod
    Granules India's Generic ADHD Drug Gets FDA Nod
    NDTV Profit
    Granules has received approval in the first review cycle.
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. has gained 14.26% in the last 1 Week
    Granules India gets US regulator FDA's approval for generic ADHD drug
    Business Standard | 17 Dec 2024
    logo
    Indoco Remedies Ltd.
    17 Dec 2024
    253.25
    1.08%
    Indoco share gains 2%; Indoco's Goa unit gets OAI status from USFDA
    Business Line
    According to its exchange filing, the USFDA inspection has conducted from July 16 to July 26, 2024, identified significant compliance issues at the facility
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd. is trading below its 100 day SMA of 262.9
    Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning
    NDTV Profit | 17 Dec 2024 1 more
    Indoco Remedies plunges 8% after warning letter from USFDA for Goa unit
    Business Standard | 17 Dec 2024
    logo
    Sun Pharmaceutical Industries Ltd.
    17 Dec 2024
    1734.90
    -0.30%
    Meet Vidhi Shanghvi: Heir to 4 lakh crore business and her surprising connection with Mukesh Ambani
    Meet Vidhi Shanghvi: Heir to 4 lakh crore business and her surprising connection with Mukesh Ambani
    livemint
    Vidhi Shanghvi, daughter of Sun Pharma's Dilip Shanghvi, plays a key role in the 4.35 lakh crore healthcare empire. With a Wharton economics degree, she is Vice President at Sun Pharma and advocates for mental health through her non-profit.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below its 30 day SMA of 1747.8
    logo
    Mankind Pharma Ltd.
    17 Dec 2024
    2572.70
    0.50%
    Mankind Pharma rises on launching QIP at floor price of Rs 2,616.55
    Business Standard
    The company launched its qualified institutional placement (QIP) at a floor price of Rs 2,616.55 per share aiming to raise up to Rs 3,000 crore
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2831.00 from 3 brokers.
    Mankind Pharma Approves Share Sale Worth Rs 3,000 Crore To Institutions To Pare Debt
    NDTV Profit | 17 Dec 2024
    logo
    Lupin Ltd.
    17 Dec 2024
    Estimates Beat
    2068.40
    -0.22%
    Lupin Share Price Live blog for 17 Dec 2024
    Lupin Share Price Live blog for 17 Dec 2024
    livemint
    Lupin Share Price Today Live Updates : Lupin stock price went up today, 17 Dec 2024, by 0.94 %. The stock closed at 880.8 per share. The stock is currently trading at 889.05 per share. Investors should monitor Lupin stock price closely in the coming days and weeks to see how it reacts to the news.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.
    logo
    Cipla Ltd.
    17 Dec 2024
    Estimates Beat
    1499.90
    -0.15%
    Cipla shares rise over 2% as Kotak forecasts better days ahead, upgrades rating to buy'
    Cipla shares rise over 2% as Kotak forecasts better days ahead, upgrades rating to buy'
    Economic Times
    Cipla shares rose by 2.4% to Rs 1,483.40 on Tuesday after Kotak Institutional Equities upgraded the stock from "add" to "buy," with a target price of Rs 1,725. This suggests a potential upside of over 16% from the current levels.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1707.30 from 10 brokers.
    Cipla shares gain; Kotak upgrades stock to 'Buy' from 'Add'; check target
    Business Standard | 17 Dec 2024
    logo
    Piramal Pharma Ltd.
    17 Dec 2024
    Capex Estimates Miss
    204.87
    -1.79%
    Piramal Pharma share price jumps 4.5% after JM Financial issues 'buy' rating, sees 36% upside
    Piramal Pharma share price jumps 4.5% after JM Financial issues 'buy' rating, sees 36% upside
    livemint
    JM Financial has initiated coverage on Piramal Pharma with a 'Buy' rating and a target price of 340, reflecting a 36% upside potential. The firm anticipates over 17% CAGR growth in Piramal's CDMO business, driven by strong demand and competitive advantages in the expanding CRDMO industry.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 266 to 257 in Mar 2025 qtr
    Piramal Pharma up 7% as JM Financial initiates with 'Buy'; 36% upside eyed
    Business Standard | 17 Dec 2024 1 more
    JM Financial Initiates 'Buy' On Piramal Pharma Citing Robust Pipeline, Global Manufacturing Presence
    NDTV Profit | 17 Dec 2024
    logo
    Wockhardt Ltd.
    16 Dec 2024, 07:54PM
    1330.40
    3.66%
    Wockhardt's Zaynich gives new hope to cancer patient with successful liver transplant
    Business Line
    The drug effectively cleared a chronic bile duct infection, enabling the patient to undergo a liver transplant and resume chemotherapy.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. is trading above its 200 day SMA of 1240.9
    Wockhardt Share Price At Life High As Patent Drug Aids US Patient With Transplant Surgery
    NDTV Profit | 16 Dec 2024, 12:37PM 1 more
    Wockhardt shares rise 10% after Zaynich aids successful liver transplant trial
    Economic Times | 16 Dec 2024, 10:27AM
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd